US scientists say they have successfully tweaked a common heart drug to make it fight cancer. Digoxin or digitalis, which comes from the foxglove plant, is normally used to steady the rhythm of the heart and help it beat more efficiently. Now a University of Wisconsin-Madison team has changed some of its building blocks to make it target tumours.
Office of Strategic Communication